Instruction for use: Micristin

Dosage form: tablets

Active substance: Acidum acetylsalicylicum

ATX

B01AC06 Acetylsalicylic acid

Pharmacological groups

Antiaggregants

Nosological classification (ICD-10)

G45 Transient transient cerebral ischemic attacks [attacks] and related syndromes: Ischemic neurological disorders; Acute cerebrovascular insufficiency; Repeated transient cerebral ischemia; Transient ischemic attack; Transient ischemic condition; Transient ischemic attack; Transient ischemic attack; transient ischemia; Transient cerebral ischemic attack; Transient cerebral ischemia; Transient ischemic attacks; Chronic cerebral ischemia; Drop attacks; Transient ischemic attacks; Transient ischemic cerebrovascular accident; Ischemic brain damage; Subclavian steal syndrome

I21 Acute myocardial infarction: Myocardial infarction in the acute phase; Acute Myocardial Infarction; Myocardial infarction with pathologic Q wave and without; Myocardial infarction complicated by cardiogenic shock; Infarction left ventricular; Transmural myocardial infarction; Myocardial infarction netransmuralny (subendocardial); Netransmuralny myocardial infarction; Subendocardial myocardial infarction; The acute phase of myocardial infarction; Acute myocardial infarction;Sub-acute phase of myocardial infarction; Subacute phase of myocardial infarction; Thrombosis of the coronary arteries (the arteries); Threatened myocardial infarction; Myocardial infarction without Q wave

I61 Intracerebral bleeding: apoplectic shock; Apoplexy of the brain; Hematoma subduralnoy; Hematoma epidural; Hemorrhagic stroke; Stroke apoplexy; Hemorrhagic stroke; Hemorrhage in the brain; Intra cerebral hemorrhage; Intra cerebral hemorrhage; Postponed hemorrhagic stroke; Subdural hematoma chronic; Epidural hematomas

I74 Embolism and arterial thrombosis: Thrombosis of effort (stress); Arterial thrombosis; Arteriothrombosis; Subacute and chronic arterial thrombosis; Subacute thrombosis of peripheral arteries; Postoperative thrombosis; Vascular thrombosis; Vascular embolism; Thrombosis of aortocoronary shunt; Arterial thrombosis; Thrombosis of arteries; Coronary artery thrombosis; Coronary thrombosis; Thrombosis of blood vessels; Thrombosis with ischemic stroke; Thrombosis with general surgical operations; Thrombosis in Oncology Operations; Vascular thrombosis; Thrombus formation in the postoperative period; Thrombotic complications; Thromboembolic diseases; Thromboembolic syndrome; Thromboembolic complication in the postoperative period; Thromboembolism of arteries; Partial vascular thrombosis; Embolism; Embolism of arteries

I80 Phlebitis and thrombophlebitis: Diseases of peripheral vessels; Inflammation of superficial veins; Inflammatory diseases of veins; Deep venous thrombophlebitis; The disease of veins; Disease of the veins of the lower extremities; Diseases of peripheral vessels; Migrating phlebitis; Insufficiency of veins of lower extremities; Exacerbation of chronic thrombophlebitis; Acute thrombophlebitis; Acute thrombophlebitis of superficial veins; Periphlebitis; Periflebit surface; Superficial inflammation of veins; Surface thrombophlebitis; Surface phlebitis; Thrombophlebitis; Deep vein thrombophlebitis; Thrombophlebitis superficial; Phlebitis; Phlebitis of deep veins; Phlebitis of superficial veins; Phlebopathy; Chronic thrombophlebitis; Endophlebitis

I82 Embolism and thrombosis of other veins: Recurrent venous thrombosis; Postoperative thrombosis; Venous thrombosis; Acute venous thromboembolism; Recurrent vein thrombosis; Venous thrombosis; Thrombosis of veins of internal organs; Venous thrombosis; Deep vein thrombosis; Thrombosis of blood vessels; Vascular thrombosis; Thrombosis of veins; Deep vein thrombosis; Thromboembolic diseases; Thromboembolism of veins; Severe venous thrombosis; Embolism; Embolism of veins; Thromboembolic complications

R07.2 Pain in the heart: neuroses of the heart; Myocardial ischemic pain; Pain syndrome in myocardial infarction; cardialgia; cardioneurosis; Cardiac syndrome; Pain in cardiac patients; Cardialgia on background dyshormonal myocardial dystrophy; Functional cardialgia; Psevdostenokardiya; pericardial pain

Structure and Composition

1 sustained-release tablet contains 500 mg of microencapsulated acetylsalicylic acid, in a package of 20 and 100 pcs.

Pharmachologic effect

Mode of action - antiaggregatory.

Dosing and Administration

Prevention of thrombosis, myocardial infarction with unstable angina, as well as repeated myocardial infarction. Prevention of cerebral stroke and transient ischemic attacks. Inflammation of superficial veins.

Contradictions

Hypersensitivity to salicylates, peptic ulcer of the stomach and duodenum, chronic gastritis, hemorrhagic diathesis, bronchial asthma, impaired renal and hepatic function, pregnancy, lactation.

Side effects

Dyspeptic disorders, liver dysfunction, increased blood loss in small operations, in rare cases, hidden gastrointestinal bleeding, tinnitus, dizziness, iron deficiency anemia, water-salt metabolism and renal activity, allergic reactions.

Interaction

Strengthens the effect of anticoagulants, sulfonylureas, NSAID, increases the toxicity of methotrexate, reduces the effect of diuretics, uricosuric drugs. Ulcerogenic effect potentiates caffeine, alcohol, weaken cimetidine, antacids, glucagon.

Dosage and Administration

Inside to 1 / 2-1 table. In the evening after a meal, drinking with water, with phlebitis up to 3 tablets per day.

Storage conditions of the drug Micristin

In a dry, cool, dark place.

Keep out of the reach of children.

The shelf life of the drug Micristin

3 years.

Do not use beyond the expiration date printed on the package.